Logo
x

Search

Subscribe Now

Protagonist

Protagonist Reports Results of PN-943 in P-II (IDEAL) Study for the Treatment of Ulcerative Colitis

Protagonist Reports Results of PN-943 in P-II (IDEAL) Study for the Treatment of Ulcerative Colitis

  • April 27, 2022
Protagonist Collaborates with Janssen to Advance PN-235 (JNJ-77242113) in P-II Clinical Studies for Multiple Indications

Protagonist Collaborates with Janssen to Advance PN-235 (JNJ-77242113) in P-II Clinical Studies for Multiple Indications

  • December 3, 2021
PharmaShots Weekly Snapshots (October 11 - 15, 2021)

PharmaShots Weekly Snapshots (October 11 - 15, 2021)

  • October 15, 2021
PharmaShots Weekly Snapshots (July 26 - 30, 2021)

PharmaShots Weekly Snapshots (July 26 - 30, 2021)

  • July 30, 2021
Janssen (J&J) Expands its PTG-200 Collaboration with Protagonist for Second Generation Oral IL-23 Receptor Antagonists

Janssen (J&J) Expands its PTG-200 Collaboration with Protagonist for Second Generation Oral IL-23 Receptor Antagonists

  • May 9, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.